ExodusPoint Capital Management’s Medpace MEDP Stock Holding History

ExodusPoint Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,741	Closed	-$1.54M	–	1883
2025 Q4	$1.54M	Buy	+2,741	New	+$1.56M	0.01%	849
2023 Q4	–	Sell	-3,462	Closed	-$838K	–	1822
2023 Q3	$838K	Sell	3,462 -9,940	-74%	-$2.54M	0.01%	1020
2023 Q2	$3.22M	Sell	13,402 -3,925	-23%	-$815K	0.03%	606
2023 Q1	$3.26M	Buy	17,327 +6,530	+60%	+$1.35M	0.03%	683
2022 Q4	$2.29M	Sell	10,797 -1,730	-14%	-$346K	0.03%	583
2022 Q3	$1.97M	Buy	+12,527	New	+$2M	0.03%	807
2022 Q2	–	Sell	-1,341	Closed	-$219K	–	2236
2022 Q1	$219K	Sell	1,341 -6,874	-84%	-$1.13M	﹤0.01%	1878
2021 Q4	$1.79M	Buy	+8,215	New	+$1.72M	0.02%	807
2020 Q4	–	Sell	-30,004	Closed	-$3.35M	–	2211
2020 Q3	$3.35M	Buy	+30,004	New	+$3.47M	0.07%	255

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

ExodusPoint Capital Management's MEDP Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 2,741 shares — an estimated $1.54M sold.

ExodusPoint Capital Management first reported a position in MEDP in Q3 2020 and held it in 9 quarters. The position peaked at $3.35M in Q3 2020. 734 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

ExodusPoint Capital Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 2,741 Medpace shares in Q1 2026, an estimated $1.54M.
ExodusPoint Capital Management first reported a position in Medpace in Q3 2020 and held it in 9 quarters.
ExodusPoint Capital Management's Medpace position peaked at $3.35M in Q3 2020.
734 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.